Investigation of the Faecal Loss of Vedolizumab and Its Role in Influencing Serum Drug Levels, Outcomes and Response in Ulcerative Colitis
Clinical trial NCT04006080 · UNKNOWN
Trial details
- NCT number
- NCT04006080
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-01
- Primary completion
- 2020-03-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.